Protein Design Labs, Seattle Genetics deal

The companies expanded a 2001 antibody-drug conjugate (ADC) deal between SGEN and Eos Biotechnology, which was acquired by PDLI last year. As expanded, PDLI may obtain exclusive licenses to SGEN's ADC...